查看完整行情页>>

|

货币单位:美元(USD)

Khosla Ventures Acquisition Co. (kvsa)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Peter S. Buckland Peter S. Buckland is currently a Partner, Managing Director & COO at Khosla Ventures LLC, a Partner at Weil, Gotshal & Manges LLP, and COO, CFO, Secretary & Treasurer at Khosla Ventures Acquisition Co. III, Khosla Ventures Acquisition Co., and Khosla Ventures Acquisition Co. IV. He is also the Chief Operating Officer at Khosla Ventures IFSPV II-A, LLC, Khosla Ventures IFSPV II-B LLC, and Khosla Ventures CFS SPV LLC. Previously, he worked as a Partner & Vice Chairman-Corporate Group at Wilmer Cutler Pickering Hale & Dorr LLP, a Principal at Brobeck, Phleger & Harrison LLP, and a Partner at WilmerHale LLP. He received his undergraduate degree from the University of California, Santa Barbara in 1993 and his graduate degree from the University of San Francisco School of Law in 1997.
Samir Kaul Samir Kaul is the founder of Cilion, Inc. (founded in 2006) and Khosla Ventures Acquisition Co. II (founded in 2021). He is also the founder of Khosla Ventures Acquisition Co. (founded in 2021). Mr. Kaul's current job(s) include being the President, Chief Executive Officer & Director at Khosla Ventures Acquisition Co. IV (since 2021). He is also a Director at Soraa, Inc., SunBorne Energy Holdings LLC, Neurotrack Technologies, Inc., Pymetrics, Inc., UCSF Benioff Children's Hospital Oakland, Inaeris Technologies LLC, Unreal Brands, Inc., Thync Global, Inc., Impossible Foods, Inc., Ukko Inc., Pivot Health Technologies, Inc., Siolta Therapeutics, Inc., Rightway Healthcare, Inc., Bionaut Labs, Inc., United States Ski Association, Khosla Ventures Associates II LLC, and Khosla Ventures Associates III LLC. Mr. Kaul's former job(s) include being the Chief Executive Officer & Director at Epitome Biosystems, Inc. and Helicos Biosciences Corp. He is also the President, Chief Executive Officer & Director at Khosla Ventures Acquisition Co. III (from 2021 to 2023). Additionally, he served as an Independent Director at Amyris, Inc. (from 2006 to 2012), Coskata, Inc., Gevo, Inc. (from 2013 to 2014), Guardant Health, Inc. (from 2014 to 2024), and D8 Holdings Corp. He was a Principal at Morphotek, Inc. and LS Dissolution, Inc.Mr. Kaul's education history includes a graduate degree from the University of Maryland (conferred in 1997), an undergraduate degree from the University of Michigan (conferred in 1995), and an MBA from Harvard Business School (conferred in 2002). Mr. Kaul is also the founder of Codon Devices, Inc., PullString, Inc...
Molly Joel Coye Molly Joel Coye was the founder and former Chief Executive Officer of Health Technology Center, which was founded in 2000. She is currently serving as an Independent Director at Amedisys, Inc., Ginger.io, Inc., SameSky Health, Inc., and Khosla Ventures Acquisition Co. She is also a Director at Headspace, Inc., Headspace Health, Curai, Inc., SFJAZZ, and a Member of the National Academy of Medicine (United States) and the National Academy of Medicine. Previously, she held positions such as Interim-President, CEO & Director at the Program for Appropriate Technology in Health, President & Chief Executive Officer at The California Regional Health Information Organization, Chairman of the American Public Health Association, Chairman of Path, Inc. (California), and Chairman of Togetherall Ltd. She was also a Director at Aetna, Inc., Aetna Foundation, Inc., Prosetta Biosciences, Inc., China Medical Board of New York, Inc., and the American Telemedicine Association. Additionally, she served as the Director-Emeritus of The California Endowment Fund and held various roles at The Lewin Group, Inc., Good Samaritan Health System, HealthDesk Corp., The Johns Hopkins University, Health Evolution Management Co. LLC, New Jersey State Department of Health & Senior Services, and UCLA Health Systems. Dr. Coye has a graduate degree from Johns Hopkins Bloomberg School of Public Health and a doctorate degree from The Johns Hopkins University School of Medicine.
Mario Tobias Schlosser Mario Tobias Schlosser is the founder of Oscar Insurance Co. (founded in 2012), Oscar Health, Inc. (founded in 2012), Vostu Ltd. (founded in 2007), and Oscar Health Agency, Inc. (founded in 2012). He holds the title of Director & President-Technology at Oscar Health, Inc. and Chief Scientist at Vostu Ltd. He is currently the Chief Executive Officer & Director at Oscar Health Plan, Inc., Chief Executive Officer at Oscar Health Plan of New York, Inc., and Independent Director at Khosla Ventures Acquisition Co. Mr. Schlosser previously worked as an Associate at Bridgewater Associates LP. He completed his undergraduate studies at the University of Hannover and holds an MBA from Harvard Business School.
Rajiv J. Shah Rajiv J. Shah was the founder of Latitude Capital Partners LLC (2015), where he served as the Managing Partner from 2015 to 2017. He is also the founder of National Institute of Food & Agriculture (District Columbia). Dr. Shah's current job(s) include Vice Chairman at PanTheryx, Inc. since 2019, Independent Director at Omeros Corp. since 2015, Director at International Rescue Committee, Inc., Director at The Atlantic Council of the United States, Independent Director at Khosla Ventures Acquisition Co. since 2021, Director at Altos Labs, Inc., Director at Mobius Science Center, Trustee at The National Geographic Society, Inc. since 2020, and President & Trustee at The Rockefeller Foundation. He is also a Food Chain Advisory Board Member at Paine Schwartz Partners LLC. Dr. Shah's former job(s) include Independent Director at Arcadia Biosciences, Inc. from 2015 to 2017, Director at The Nature Conservancy, Inc., Director at Bill & Melinda Gates Foundation from 2001 to 2009, Administrator at US Agency for International Development from 2010 to 2015, and Chief Scientist & Undersecretary at USDA Rural Development from 2009 to 2010. Dr. Shah's education history includes an undergraduate degree from the University of Michigan, a graduate degree from The Wharton School of the University of Pennsylvania, and a doctorate degree from Perelman School of Medicine.
Dmitri Shklovsky Dmitri Shklovsky is the founder of Atreaus Capital LLC, which was founded in 2011. He held the title of Managing Partner at Atreaus Capital LLC. Mr. Shklovsky is also the founder of Bullingham Capital. Mr. Shklovsky's current job(s) include being an Independent Director at Khosla Ventures Acquisition Co. since 2021, a Trustee at Cornell University, and a Trustee at the U.S. Olympic & Paralympic Foundation. Mr. Shklovsky's former job includes being an Independent Director at Khosla Ventures Acquisition Co. II. Mr. Shklovsky's education history includes undergraduate and graduate degrees from Cornell University.